We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Strengths and weaknesses of pneumococcal conjugate vaccines

    Multivalent vaccines addressing an increasing number of Streptococcus pneumoniae types (7-, 10-, 13-, 15-, 20-valent) have been licensed over the...

    Francesca Micoli, Maria Rosaria Romano, ... Francesco Berti in Glycoconjugate Journal
    Article Open access 18 January 2023
  2. Innovative Vaccine Strategy: Self-Adjuvanting Conjugate Vaccines

    Self-adjuvanting vaccines, covalent conjugates between antigens and adjuvants, are chemically well-defined compared with conventional vaccines...
    Yoshiyuki Manabe, Koichi Fukase in Glycolipids
    Protocol 2023
  3. Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate

    Glioblastoma is the most common and aggressive primary brain tumour in adults. The development of anti-brain cancer agents are challenged by the...

    Elizabeth Cooper, Caitlin R. M. Oyagawa, ... Thomas I-H. Park in Cell Communication and Signaling
    Article Open access 11 January 2024
  4. Heterologous Expression of Recombinant Proteins and Their Derivatives Used as Carriers for Conjugate Vaccines

    Abstract

    Carrier proteins that provide an effective and long-term immune response to weak antigens has become a real breakthrough in the disease...

    Yuliya A. Khodak in Biochemistry (Moscow)
    Article 22 September 2023
  5. A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy

    Transcatheter arterial chemoembolization (TACE) has become the preferred therapy for unresectable advanced hepatocellular carcinoma (HCC). However,...

    Dongyuan Wang, Jiacheng Liu, ... Bin **ong in Cell Death Discovery
    Article Open access 06 October 2022
  6. Hybrid Antimicrobial Coating Based on Conjugate of Hyaluronic Acid with LL-37 Peptide for PEO-Modified Titanium Implants

    Abstract

    Objective: Synthesis of a novel conjugate of hyaluronic acid (HA) and the antimicrobial peptide LL-37 and evaluation of its antibacterial...

    L. V. Parfenova, Z. R. Galimshina, ... E. V. Parfenov in Russian Journal of Bioorganic Chemistry
    Article 09 April 2024
  7. Designing a novel drug–drug conjugate as a prodrug for breast cancer therapy: in silico insights

    Breast cancer (BC) poses a significant global health threat, necessitating innovative therapeutic approaches. The ribosomal s6 kinase 2 (RSK2) has...

    Sankar Muthumanickam, Balajee Ramachandran, ... Boomi Pandi in Molecular Diversity
    Article 04 June 2024
  8. Combined therapy of dabrafenib and an anti-HER2 antibody–drug conjugate for advanced BRAF-mutant melanoma

    Background

    Melanoma is the most lethal skin cancer characterized by its high metastatic potential. In the past decade, targeted and immunotherapy have...

    Weisong Li, Chao Zheng, ... Shuyong Zhang in Cellular & Molecular Biology Letters
    Article Open access 10 April 2024
  9. Production and characterisation of modularly deuterated UBE2D1–Ub conjugate by small angle neutron and X-ray scattering

    This structural study exploits the possibility to use modular protein deuteration to facilitate the study of ubiquitin signalling, transfer, and...

    Zuzanna Pietras, Anthony P. Duff, ... Maria Sunnerhagen in European Biophysics Journal
    Article Open access 26 October 2022
  10. Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer

    Colorectal cancer (CRC) is the third most common cancer associated with a poor prognosis. Effective targeted therapy alone or in combination for...

    Hongfu Liu, Dongdong Zhou, ... Shuyong Zhang in Cell Death & Disease
    Article Open access 05 March 2024
  11. Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®

    Bacterial capsular polysaccharide vaccines are generally poorly immunogenic in infants and older adults. The immunogenicity of capsular...

    Richard Kensinger, Arun B. Arunachalam in Glycoconjugate Journal
    Article Open access 20 April 2022
  12. Synthesis and Characterization of Dipeptide–Drug Conjugate: The Use of Linker Coupling Reaction

    Most of the effective anticancer drugs available in the market suffer from adverse effects due to their lack of target specificity. Therefore, so...

    Deepthi Ramamurthi, Jubie Selvaraj, ... Moola Joghee Nanjan Chandrasekar in International Journal of Peptide Research and Therapeutics
    Article 17 January 2022
  13. Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics

    The COVID-19 crisis, incited by the zoonotic SARS-CoV-2 virus, has quickly escalated into a catastrophic public health issue and a grave threat to...

    Mamta Panda, Elora Kalita, ... Vijay Kumar Prajapati in Molecular Diversity
    Article 18 November 2022
  14. Assessing the Potential of Vitamin Drug Conjugate for Its Activity against Infectious Disease

    Abstract

    Objective: This study explores vitamin drug conjugates, linking drugs to targeting moieties (Niacin and Pantothenic acid), aiming to enhance...

    R. P. Bhole, P. C. Bhondave, R. V. Chikhale in Russian Journal of Bioorganic Chemistry
    Article 13 February 2024
  15. Copper-catalyzed C2-selective alkynylation of chromones via 1,4-conjugate addition

    Copper-catalyzed selective alkynylation with N -propargyl carboxamides as nucleophiles has been successfully developed for the synthesis of...

    Yan-Wu Li, Jie Lei, ... Meng-Lan Lv in Molecular Diversity
    Article 07 March 2023
  16. Serotype-specific quantification of residual free polysaccharide in multivalent pneumococcal conjugate vaccines

    The Streptococcus pneumoniae bacteria has over 100 known serotypes that display a continuous change in prevalence by patients’ age and geographical...

    Milica Grozdanovic, Rachelle Samuel, ... Frances Ansbro in Glycoconjugate Journal
    Article 15 January 2024
  17. A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway

    Human epidermal growth factor receptor 2 (HER2) is a protein that is overexpressed in some types of cancer, including breast and urothelial cancer....

    **aohan Wu, Lingyan Xu, ... Yanhong Gu in Cell Death & Disease
    Article Open access 24 August 2023
  18. LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma

    Despite clinical advances in diagnosis and treatment, pancreatic ductal adenocarcinoma (PDAC) remains the third leading cause of cancer death, and is...

    Angélina Acier, Magali Godard, ... Fabienne Guillaumond in Communications Biology
    Article Open access 19 August 2021
  19. Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer

    To explore highly selective targeting molecules of colorectal cancer (CRC) is a challenge. We previously identified a twelve-amino acid peptide...

    Lidan Hou, Yichao Hou, ... **angjun Meng in Communications Biology
    Article Open access 14 November 2022
Did you find what you were looking for? Share feedback.